These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32429133)

  • 1. M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis.
    Badmann S; Heublein S; Mayr D; Reischer A; Liao Y; Kolben T; Beyer S; Hester A; Zeder-Goess C; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
    Cells; 2020 May; 9(5):. PubMed ID: 32429133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
    Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J
    Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MDR1 in epithelial ovarian cancer and its association with disease progression.
    Lu L; Katsaros D; Wiley A; Rigault de la Longrais IA; Puopolo M; Yu H
    Oncol Res; 2007; 16(8):395-403. PubMed ID: 17913048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
    Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
    Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancer.
    Czogalla B; Kuhn C; Heublein S; Schmöckel E; Mayr D; Kolben T; Trillsch F; Burges A; Mahner S; Jeschke U; Hester A
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2519-2527. PubMed ID: 31485769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma.
    Shimbo A; Kajiyama H; Tamauchi S; Yoshikawa N; Ikeda Y; Nishino K; Suzuki S; Niimi K; Sakata J; Kikkawa F
    Oncol Rep; 2019 Dec; 42(6):2323-2332. PubMed ID: 31578579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of Semaphorin4D indicates poor prognosis and prompts monocyte differentiation toward M2 macrophages in epithelial ovarian cancer.
    Chen Y; Zhang L; Lv R; Zhang WQ
    Asian Pac J Cancer Prev; 2013; 14(10):5883-90. PubMed ID: 24289594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
    Wang J; Zhao S; Wang F; Wang J; Zhang Y
    Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence.
    Chen XY; Thike AA; Md Nasir ND; Koh VCY; Bay BH; Tan PH
    Virchows Arch; 2020 Jun; 476(6):825-833. PubMed ID: 31897820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study.
    Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM
    BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.
    Pylväs-Eerola M; Karihtala P; Puistola U
    BMC Cancer; 2015 Jul; 15():493. PubMed ID: 26134400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High histone H3K18 lactylation level is correlated with poor prognosis in epithelial ovarian cancer.
    Chao J; Chen GD; Huang ST; Gu H; Liu YY; Luo Y; Lin Z; Chen ZZ; Li X; Zhang B; Xu X; He S
    Neoplasma; 2024 Aug; 71(4):319-332. PubMed ID: 39267539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer.
    Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH
    BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer.
    Zeng Y; Chen M; Ganesh S; Hu S; Chen H
    PLoS One; 2020; 15(5):e0232235. PubMed ID: 32401768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omental Macrophagic "Crown-like Structures" Are Associated with Poor Prognosis in Advanced-Stage Serous Ovarian Cancer.
    Liang YL; Lin CN; Tsai HF; Wu PY; Lin SH; Hong TM; Hsu KF
    Curr Oncol; 2021 Oct; 28(5):4234-4246. PubMed ID: 34677277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High density of stroma-localized CD11c-positive macrophages is associated with longer overall survival in high-grade serous ovarian cancer.
    Corvigno S; Mezheyeuski A; De La Fuente LM; Westbom-Fremer S; Carlson JW; Fernebro J; Åvall-Lundqvist E; Kannisto P; Hedenfalk I; Malander S; Rolny C; Dahlstrand H; Östman A
    Gynecol Oncol; 2020 Dec; 159(3):860-868. PubMed ID: 33032823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.